ASPHF
Ascentage Pharma Group International
Set alert
3.75 USD 0.00 0.00%
3.46 Day range 3.46
3.46 52-week range 9.32
- YTD
- -55.78%
- 1 year
- -59.76%
- Open
- 3.46
- Prev close
- 3.75
- Mkt cap
- 1.40B
- Vol
- 100
- Avg vol
- 104
- EPS
- -0.56
- P/E
- 0.00
More statistics
- Low
- 3.46
- High
- 3.46
- Earnings
- Aug 26, 2026
Next earnings
Aug 26, 2026
Expected Aug 26, 2026. Consensus EPS estimate -0.05522.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jun 30, 2026 | -0.05522 | — | — | — |
| Mar 24, 2026 | Dec 31, 2025 | -0.20929 | -0.16035 | +0.05 | +23.38% |
| Aug 20, 2025 | Jun 30, 2025 | — | -0.24142 | — | — |
| Mar 27, 2025 | Dec 31, 2024 | 0.00411 | 0.00411 | 0.00 | 0.00% |
| Aug 22, 2024 | Jun 30, 2024 | — | 0.07566 | — | — |
| Mar 27, 2024 | Dec 31, 2023 | — | -0.25415 | — | — |
News
- Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript
- Ascentage Pharma Group International (AAPG) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
- Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Increase in Short Interest
- Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Ascentage Pharma Group International (OTCMKTS:ASPHF) Stock Price Down 23.4% – Should You Sell?
- Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update
- Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript
- Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO
- Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO
- Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
Your note
Sign in to keep a note on ASPHF — it syncs with the Stock Master app.